(A) qRT-PCR analysis of Adamts6 and Adamts10 mRNA levels in wild type, Adamts6-/- and Adamts10-/- limb, heart and lung show that Adamts6 mRNA is elevated in Adamts10-/- limb, heart and lung and Adamt…
(A) ADAMTS10 was co-transfected with ADAMTS6 or the catalytically inactive mutant ADAMTS6 EA. (B) Furin site-optimized ADAMTS10 (ADAMTS10-RRKR) was co-transfected with ADAMTS6 EA. No cleavage …
Mendelian ratios obtained from Adamts6+/- intercrosses (A) and Adamts6+/-;Adamts10+/- intercrosses at E18.5 (B) are shown. Observed and expected (in parentheses) genotype percentages are shown in …
At E14.5 (A) and E16.5 (B), Adamts6-deficient embryos have reduced crown-rump length and shorter long bones as compared to wild type embryos. Crown-rump length, n = 4; bone length, n ≥ 6. *p ≤ 0.05; …
(A) Adamts6- and Adamts10-deficient embryos and embryos with various combinations of alleles have reduced crown-rump length as compared to wild type embryos. (B) Embryos with various combinations of …
E18.5 Adamts6-deficient embryos have wider long bones than wild type embryos. n ≥ 6. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
Alcian blue-stained sections show the primary ossification center in E14.5 wild type femur (lack of blue staining in the diaphysis). The primary center did not form until E16.5 in the Adamts6-/- …
Alcian blue-stained sections revealed marked distal tibial angulation in Adamts6-/- hindlimbs as early as E14.5, which persisted and contributed to a club-foot like appearance of the hindlimbs. n ≥ 4.
Alcian blue-stained sections revealed a delay in chondrocyte hypertrophy until E16.5 in Adamts6-/- fibula whereas it occurred at E14.5 in wild type fibula. Similarily, ossification was delayed until …
(A,B) E14.5 von Kossa-stained sections (A) quantified in (B) revealed reduced mineral deposition (black) in Adamts6-/- hindlimb bones. Significant staining in the periosteum as well as in the center …
Alcian blue- and alizarin red -stained E18.5 axial skeleton and craniofacial preparations show that Adamts6-/- and Adamts6-/-;Adamts10-/- embryos have shortened, stout ribs (asterisks), shortened …
(A) RNAscope in situ hybridization shows strong expression of Adamts6 and Adamts10 in E13.5 perichondrium (arrow) and weaker expression in growth plate chondrocytes (arrowheads). (B) Strong Adamts6 …
(A) RGB trichrome-stained E18.5 knees show disorganized chondrocytes and reduced alcian blue staining in Adamts6-/- and Adamts6-/-;Adamts10-/- bones. (F), femur; T, tibia; f, fibula; RZ, resting …
RGB trichrome-stained E18.5 femur showed diffuse, disorganized and increased collagen staining (red) in the perichondrium and adjacent mesenchyme in Adamts6-/- and Adamts6-/-;Adamts10-/- embryos. …
(A) RGB trichrome-stained E14.5 Adamts6-/- femur sections show smaller resting zone (RZ), columnar zone (CZ) and hypertrophic zone (HZ) chondrocytes with reduced alcian blue staining of the ECM. (B, …
Reduced staining intensity of aggrecan (Acan), cartilage link protein (CLP) and Sox9 were evident in Adamts6-/- proximal femoral resting and columnar zone chondrocytes. No change in Col X staining …
(A–B) PCNA +nuclei (red) (A) in E18.5 distal femur were quantified in the resting zone (RZ; yellow brackets) and columnar zone (CZ; orange brackets) and quantified in (B). n = 4. (C–D) TUNEL +cells …
(A–B) Increased staining intensity (green) of MAGP1 (A) and fibrillin-2 (B) in E18.5 Adamts6- and Adamts10-deficient knee joints. (C) No consistent change in fibrillin-1 staining (green) was seen …
(A) Increased MAGP1 and fibrillin-2 staining intensity in Adamts6- and Adamts10-mutant hindlimbs. There was no change, however, in fibrillin-1 staining intensity. n ≥ 4. *p ≤ 0.05; **p ≤ 0.01; ***p …
(A) Fbn1-/- mouse embryo fibroblasts (MEFs), which can produce fibrillin-2 but not fibrillin-1, were cocultured with human embryonic kidney (HEK) cells overexpressing ADAMTS6 or ADAMTS6 EA (inactive …
(A) Adamts6-/- mouse embryo fibroblasts (MEFs) have increased fibrillin-2 and fibrillin-1 staining after 6 days in culture as compared to wild type MEFs. Fibronectin staining was similarly increased …
(A) Cartoons of the domain structures of ADAMTS6 and fibrillin-2 and the recombinant constructs used in the present work (indicated by black lines). (B–C) Biacore analysis shows dose-dependent …
(A) Domain structure of fibrillin-1 recombinant constructs. (B) Biacore analysis shows that fibrillin-1-Nt and fibrillin-1-Ct recombinant fragments each bind strongly to ADAMTS6-Ct. (C). Comparison …
(A) Schematic of the experimental approach. Proteins from conditioned medium of co-cultures of HEK293F cells stably expressing FBN2-Ct and HEK293F cells expressing either ADAMTS6 WT or ADAMTS6 EA …
(A) Schematic of the experimental approach. Proteins from conditioned medium of co-cultured HEK293F cells stably expressing fibrillin-1 and HEK293F cells expressing either ADAMTS6 WT or ADAMTS6 EA …
(A) Schematic of the domain structure of fibronectin and locations of the identified cleavage sites. (B–C) Annotated MS2 spectra of the VREEVVTVGNSVNEG (B) and the LNQPTDDSCFDPYTVSHYAVGDEWER (C) …
(A–B) Deletion of one Fbn2 allele reverses limb dysmorphology in E18.5 Adamts6-/- embryos, specifically, externally evident limb segment dimensions and reversal of rotational anomaly (arrow) (A), …
Reduced crown-rump length (A) and reduced radius, ulna, tibia and fibula length (B) in E18.5 Adamts6-/- embryos was ameliorated by Fbn2 heterozygosity. Crown-rump length, n ≥ 3; bone length, n ≥ 6. …
The images specifically illustrate restoration of length, ossification and relative proportions of the ribs (astrisks), sternal segmental ossific centers (arrows) and xiphoid process ossification …
Reduction of fibrillin-2 staining intensity was noted in Adamts6-/-;Fbn2+/- hindlimbs compared to Adamts6-/- hindlimbs. Fbn2+/- hindlimbs also had reducedfibrillin-2 staining than wild type …
(A,B) Alcian blue- and alizarin red-stained E18.5 Fbn2+/- hindlimbs have normal patterning and unchanged long bone length (n ≥ 12). No change in crown-rump length was seen in E18.5 Fbn2+/- embryos …
No restoration of long bone dysmorphology and shortening (A,B) or crown-rump length (B) of Adamts6-/- embryos after hemizygosity or homozygosity for a Fbn1 mutant allele, Fbn1mgR. Measurements were …
(A) Reduced pSMAD1/5/8 staining in Adamts6-/- femur, as compared to wild type control, is restored to wild type levels in Adamts6-/-;Fbn2+/- femur as quantified in (B). n ≥ 4; *p ≤ 0.05; **p ≤ 0.01. …
(A–B) E14.5, E16.5 and E18.5 Adamts6-/- knee joints (A) and perichondrium (B) show both increased fibrillin-2 (red) and GDF5 (green) staining in joint mesenchyme as compared to wild-type control. …
Quantification of fluorescent staining intensity in sections of the E14.5, E16.5, and E18.5 knee joint from wild type and Adamts6-/- embyros stained with fibrillin-2 and GDF5 antibodies. n ≥ 4. *p ≤ …
(A) Adamts6 expression (pink dots) is shown in the perichondrium, peripheral chondrocytes, and in mesenchyme surrounding the knee joint. BMP signaling (blue circles) is evident in growth plate …
Ligand: FBN2-Ct | |||
---|---|---|---|
Analyte | KD (nM) | R2 | Bmax (RU) |
ADAMTS6-Ct | 436 | 0.9951 | 727 |
ADAMTS6-4TSR | 122 | 0.8864 | 188 |
ADAMTS6-S4TSR | 114 | 0.9819 | 241 |
Ligand: ADAMTS6-Ct | |||
---|---|---|---|
Analyte | KD (nM) | R2 | Bmax (RU) |
FBN2-Nt | 43 | 0.9972 | 85 |
FBN2-Ct | 80 | 0.9933 | 100 |
The cleavage site is indicated by the period in column 1, with flanking amino acids numbered.
Annotated sequence | Number of PSMs | Wild type abundance | EA abundance |
---|---|---|---|
[A292].V293YQPQPHPQPPPYGHCVTDSGVVYSVGMQWLK.[T] | 2 | 1.38E + 06 | 0 |
[Y294].Q295PQPHPQPPPYGHCVTDSGVVYSVGMQWLK.[T] | 1 | 6.99E + 05 | 0 |
[P462].M463AAHEEICTTNEGVMYR.[I] | 2 | 1.22E + 06 | 0 |
[A464].A465HEEICTTNEGVMYR.[I] | 1 | 4.71E + 05 | 0 |
[G567].T568FYQIGDSWEK.[Y] | 1 | 1.18E + 06 | 0 |
[F750].R751VEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRK.[Y] | 1 | 3.33E + 05 | 0 |
[K].YIVNVYQISEDGEQS800.[L801] | 1 | 8.57E + 05 | 0 |
[Y1248].T1249VKDDKESVPISDTIIPAVPPPTDLR.[F] | 1 | 1.21E + 06 | 0 |
[Y1613].A1614QNPSGESQPLVQTAVTTIPAPTDLK.[F]† | 1 | 6.32E + 05 | 0 |
[P2021].F2022VTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRR.[T] | 2 | 1.58E + 06 | 0 |
[K].VREEVVTVGNSVNEG2197.[L2198]* | 1 | 1.56E + 06 | 0 |
[G2197].L2198NQPTDDSCFDPYTVSHYAVGDEWER.[M]* | 1 | 6.82E + 06 | 0 |
Abbreviations used: PSM, Peptide spectrum matches.
Peptides with termini identifying the same cleavage site (G2197-L2198).
Peptide unique to the FN1-8 isoform.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Gene (Mus musculus) | Adamts6 | Genbank | NCBI Gene: 108,154 | ADAM metallopeptidase with thrombospondin type 1 motif 6 |
Gene (Mus musculus) | Adamts10 | Genbank | NCBI Gene: 224,697 | ADAM metallopeptidase with thrombospondin type 1 motif 10 |
Gene (Mus musculus) | Adamts17 | Genbank | NCBI Gene: 233,332 | ADAM metallopeptidase with thrombospondin type 1 motif 17 |
Gene (Mus musculus) | Adamts19 | Genbank | NCBI Gene: 240,322 | ADAM metallopeptidase with thrombospondin type 1 motif 19 |
Gene (Mus musculus) | Fbn1 | Genbank | NCBI Gene: 14,118 | Fibrillin-1 |
Gene (Mus musculus) | Fbn2 | Genbank | NCBI Gene: 14,119 | Fibrillin-2 |
Gene (Mus musculus) | Fn1 | Genbank | NCBI Gene: 14,268 | Fibronectin |
Strain, strain background (Mus musculus) | Adamts6b2b2029Clo (C57BL/6 J) | Mouse Genome Informatics | RRID: MGI:5487397 | Adamts6 null allele |
Strain, strain background (Mus musculus) | Adamts10tm1Dgen (C57BL/6 J) | Mouse Genome Informatics | RRID: MGI:6355992 | Adamts10 null allele |
Strain, strain background (Mus musculus) | Fbn1tm2Rmz (C57BL/6 J) | Mouse Genome Informatics | RRID: MGI:1934906 | Fbn1mgR allele |
Strain, strain background (Mus musculus) | Fbn2tm1Rmz (C57BL/6 J) | Mouse Genome Informatics | RRID: MGI:3652417 | Fbn2 null allele |
Strain, strain background (Mus musculus) | Fbn1tm3Rmz (C57BL/6 J) | PMCID:PMC3875392 | RRID: MGI:3641232 | Fbn1 null allele MEFs used for cell culture experiments |
Strain, strain background (Mus musculus) | Fbn2tm1Rmz (C57BL/6 J) | This paper | RRID: MGI:3652417 | Fbn2 null MEFs used for in vitro microfibril staining |
Strain, strain background (Mus musculus) | C57BL/6 J strain | This paper | RRID: IMSR_JAX:000664 | Wild type MEFs used for in vitro microfibril staining |
Strain, strain background (Mus musculus) | Adamts6b2b2029Clo (C57BL/6 J) | This paper | RRID: MGI:5487397 | Adamts6 mutant MEFs for in vitro microfibril staining |
Transfected construct (Mus musculus) | ADAMTS6 WT | PMCID:PMC6048820 | ADAMTS6 plasmid | |
Transfected construct (Mus musculus) | ADAMTS6 EA | This paper | This paper | Catalytically- inactive ADAMTS6 plasmid |
Cell line (human) | FBN1-expressing cells | Dieter Reinhardt, Ph.D. | PMID:12399449 | Stable HEK293 cell line expressing full length FBN1 |
Cell line (human) | FBN2-Nt-expressing cells | Dieter Reinhardt, Ph.D. | PMID:12399449 | Stable HEK293 cell line expressing the N-terminal half of FBN2 |
Cell line (human) | FBN2-Ct-expressing cells | Dieter Reinhardt, Ph.D. | PMID:12399449 | Stable HEK293 cell line expressing the C-terminal half of FBN2 |
Peptide, recombinant protein | FBN2-Nt-expressing cells | Dieter Reinhardt, Ph.D. | rFBN2-N; PMID:12399449 | Used for Biacore analysis |
Peptide, recombinant protein | FBN2-Ct | Dieter Reinhardt, Ph.D. | rFBN2-C; PMID:12399449 | Used for Biacore analysis |
Peptide, recombinant protein | FBN1-Nt | Dieter Reinhardt, Ph.D. | rFBN1-N; PMID:12399449 | Used for Biacore analysis |
Peptide, recombinant protein | FBN1-Ct | Dieter Reinhardt, Ph.D. | rFBN1-C; PMID:12399449 | Used for Biacore analysis |
Peptide, recombinant protein | FN1 | Deane Mosher, M.D. | PMD:6133865 | Used for Biacore analysis |
Peptide, recombinant protein | ADAMTS6-Ct | Stuart Cain, Ph.D. | PMCID:PMC5078793 | Used for Biacore analysis |
Peptide, recombinant protein | ADAMTS6-4TSR | Stuart Cain, Ph.D. | This paper | Used for Biacore analysis |
Peptide, recombinant protein | ADAMTS6-S4TSR | Stuart Cain, Ph.D. | This paper | Used for Biacore analysis |
Peptide, recombinant protein | ADAMTS6-TCS | Stuart Cain, Ph.D. | This paper | Used for Biacore analysis |
Antibody | Anti-Fibrillin-2-Gly(rabbit polyclonal) | Robert Mecham, Ph.D. | PMID:10825173 | IF (1:300) |
Antibody | Anti-mFbn1-C (rabbit polyclonal) | Dieter Reinhardt, Ph.D. | PMID:33039488 | IF (1:500) |
Antibody | Anti-rFBN2-C (rabbit polyclonal) | Dieter Reinhardt, Ph.D. | PMID:12399449 | WB (1:500) |
Antibody | Anti-MAGP1 (rabbit polyclonal) | Robert Mecham, Ph.D. | PMCID:PMC14862 | IF (1:200) |
Antibody | Anti-Sox9 (rabbit polyclonal) | Millipore AB5535 | RRID: AB_2239761 | IF (1:300) |
Antibody | Anti-Acan (rabbit polyclonal) | Millipore AB1031 | RRID: AB_90460 | IF (1:400) |
Antibody | Anti-CLP (mouse monoclonal) | DSHB 9/30/8 A-4 | RRID: AB_2248142 | IF (1:100) |
Antibody | Anti-Col X (rabbit polyclonal) | Abcam ab58632 | RRID: AB_879742 | IF (1:1000) |
Antibody | Anti-PCNA (mouse monoclonal) | Cell Signaling 2,586 | RRID: AB_2160343 | IF (1:200) |
Antibody | Anti-His (mouse monoclonal) | R&D MAB050 | RRID: AB_357353 | IF (1:400) WB (1:1000) |
Antibody | Anti-pSmad5 (rabbit polyclonal) | Abcam ab92698 | RRID: AB_10561456 | WB (1:1000) |
Antibody | Anti-pSmad1/5 (rabbit polyclonal) | Cell Signaling 9,516 | RRID: AB_491015 | IF (1:200) |
Antibody | Anti-pSmad2(rabbit polyclonal) | Cell Signaling 3,108 | RRID: AB_490941 | IF (1:200)WB (1:1000) |
Antibody | Anti-GDF5 (goat polyclonal) | R&D AF853 | RRID: AB_355662 | IF (1:100) |
Antibody | Anti-GAPDH (mouse monoclonal) | Millipore MAB374 | RRID: AB_2107445 | WB (1:5000) |
Commercial assay or kit | Adamts6 RNAscope probe | ACD Bio | 428,301 | Mouse ISH probe |
Commercial assay or kit | Adamts10 RNAscope probe | ACD Bio | 585,161 | Mouse ISH probe |
Commercial assay or kit | RNAscope 2.5 HD Red in situ detection kit | ACD Bio | 322,350 | Used to detect Adamts6 and Adamts10 probes |
Software, algorithm | GraphPad Prism | GraphPad | RRID: SCR_002798 | Utilized for statistical computing of data |
Software, algorithm | Fiji | NIH | RRID: SCR_002285 | Used to quantify IF tissue sections |
IF, Immunofluorescence.; WB, western blot.; ISH, in situ hybridization.
Original, unedited western blots.
Antibodies.
Quantitative Real-Time PCR primers.